» Articles » PMID: 18215437

Computing Normalised Prediction Distribution Errors to Evaluate Nonlinear Mixed-effect Models: the Npde Add-on Package for R

Overview
Date 2008 Jan 25
PMID 18215437
Citations 248
Authors
Affiliations
Soon will be listed here.
Abstract

Pharmacokinetic/pharmacodynamic data are often analysed using nonlinear mixed-effect models, and model evaluation should be an important part of the analysis. Recently, normalised prediction distribution errors (npde) have been proposed as a model evaluation tool. In this paper, we describe an add-on package for the open source statistical package R, designed to compute npde. npde take into account the full predictive distribution of each individual observation and handle multiple observations within subjects. Under the null hypothesis that the model under scrutiny describes the validation dataset, npde should follow the standard normal distribution. Simulations need to be performed before hand, using for example the software used for model estimation. We illustrate the use of the package with two simulated datasets, one under the true model and one with different parameter values, to show how npde can be used to evaluate models. Model estimation and data simulation were performed using NONMEM version 5.1.

Citing Articles

Population Pharmacokinetics of IV Lidocaine and its Metabolites in Adult Surgical Patients.

Foong K, Loh P, Chaw S, Lo Y Pharm Res. 2025; .

PMID: 40021547 DOI: 10.1007/s11095-025-03835-1.


All You Need to Know About Allometric Scaling: An Integrative Review on the Theoretical Basis, Empirical Evidence, and Application in Human Pharmacology.

van Valkengoed D, Krekels E, Knibbe C Clin Pharmacokinet. 2024; 64(2):173-192.

PMID: 39644458 PMC: 11782306. DOI: 10.1007/s40262-024-01444-6.


Semi-mechanistic population pharmacokinetic modeling of DZIF-10c, a neutralizing antibody against SARS-Cov-2: predicting systemic and lung exposure following inhaled and intravenous administration.

Kurup S, Velez de Mendizabal N, Becker S, Bolella E, De Sousa D, Fatkenheuer G J Pharmacokinet Pharmacodyn. 2024; 52(1):3.

PMID: 39636474 PMC: 11621205. DOI: 10.1007/s10928-024-09947-2.


Exposure-response modeling of liver fat imaging endpoints in non-alcoholic fatty liver disease populations administered ervogastat alone and co-administered with clesacostat.

Hughes J, Amin N, Wojciechowski J, Vourvahis M CPT Pharmacometrics Syst Pharmacol. 2024; 14(2):317-330.

PMID: 39564924 PMC: 11812935. DOI: 10.1002/psp4.13275.


External evaluation of neonatal vancomycin population pharmacokinetic models: Moving from first-order equations to Bayesian-guided therapeutic monitoring.

Blouin M, Metras M, Gaudreault C, Dube M, Boulanger M, Cloutier K Pharmacotherapy. 2024; 44(12):907-919.

PMID: 39544156 PMC: 11687215. DOI: 10.1002/phar.4623.